• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Relationship between Gleason score and apparent diffusion coefficients of diffusion-weighted magnetic resonance imaging in prostate cancer patients.前列腺癌患者中Gleason评分与扩散加权磁共振成像表观扩散系数之间的关系。
Can Urol Assoc J. 2016 Nov-Dec;10(11-12):E377-E382. doi: 10.5489/cuaj.3896. Epub 2016 Nov 10.
2
The value of ADC, T2 signal intensity, and a combination of both parameters to assess Gleason score and primary Gleason grades in patients with known prostate cancer.表观扩散系数(ADC)、T2信号强度以及这两个参数的组合在评估已知前列腺癌患者的 Gleason 评分和主要 Gleason 分级中的价值。
Acta Radiol. 2016 Jan;57(1):107-14. doi: 10.1177/0284185114561915. Epub 2014 Dec 12.
3
Analysis of Diffusion-weighted MR Images Based on a Gamma Distribution Model to Differentiate Prostate Cancers with Different Gleason Score.基于伽马分布模型的磁共振弥散加权成像分析对不同 Gleason 评分前列腺癌的鉴别诊断
Magn Reson Med Sci. 2020 Feb 10;19(1):40-47. doi: 10.2463/mrms.mp.2018-0124. Epub 2019 Mar 26.
4
Apparent diffusion coefficient values are superior to transrectal ultrasound-guided prostate biopsy for the assessment of prostate cancer aggressiveness.表观扩散系数值在评估前列腺癌侵袭性方面优于经直肠超声引导下的前列腺活检。
Acta Radiol. 2017 Feb;58(2):232-239. doi: 10.1177/0284185116639764. Epub 2016 Jul 19.
5
Quantitative evaluation of the relative apparent diffusion coefficient values on multiparametric magnetic resonance imaging to predict higher Gleason score prostate cancer.多参数磁共振成像上相对表观扩散系数值的定量评估以预测更高Gleason评分的前列腺癌。
Scand J Urol. 2018 Jun;52(3):180-185. doi: 10.1080/21681805.2018.1481143. Epub 2018 Jun 25.
6
The Utility of Diffusion-Weighted Imaging and Perfusion Magnetic Resonance Imaging Parameters for Detecting Clinically Significant Prostate Cancer.扩散加权成像和灌注磁共振成像参数在检测临床显著前列腺癌中的应用。
Can Assoc Radiol J. 2019 Nov;70(4):441-451. doi: 10.1016/j.carj.2019.07.005. Epub 2019 Sep 24.
7
Correlation of Gleason scores with diffusion-weighted imaging findings of prostate cancer.Gleason评分与前列腺癌扩散加权成像结果的相关性
Adv Urol. 2012;2012:374805. doi: 10.1155/2012/374805. Epub 2011 Dec 15.
8
Differentiation of prostate cancer lesions in the Transition Zone by diffusion-weighted MRI.通过扩散加权磁共振成像鉴别移行带前列腺癌病变
Eur J Radiol Open. 2017 Sep 29;4:123-128. doi: 10.1016/j.ejro.2017.08.003. eCollection 2017.
9
Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.多参数磁共振成像用于评估拟行根治性前列腺切除术的前列腺癌患者的包膜外侵犯及其他分期参数。
Actas Urol Esp. 2014 Jun;38(5):290-7. doi: 10.1016/j.acuro.2013.11.003. Epub 2014 Jan 1.
10
Whole-Tumor Quantitative Apparent Diffusion Coefficient Histogram and Texture Analysis to Predict Gleason Score Upgrading in Intermediate-Risk 3 + 4 = 7 Prostate Cancer.全肿瘤定量表观扩散系数直方图和纹理分析预测中危3+4=7前列腺癌的Gleason评分升级
AJR Am J Roentgenol. 2016 Apr;206(4):775-82. doi: 10.2214/AJR.15.15462. Epub 2016 Feb 2.

引用本文的文献

1
Optimizing prostate cancer detection in transition zone: an analysis of apparent diffusion coefficient values in prostate magnetic resonance imaging evaluation with Prostate Imaging Reporting and Data System (PI-RADS) assessment.优化移行区前列腺癌检测:基于前列腺影像报告和数据系统(PI-RADS)评估的前列腺磁共振成像中表观扩散系数值分析
Transl Androl Urol. 2024 Sep 30;13(9):2027-2035. doi: 10.21037/tau-24-235. Epub 2024 Sep 26.
2
Comparison of data fusion strategies for automated prostate lesion detection using mpMRI correlated with whole mount histology.基于与全组织切片病理对照的多模态 MRI 自动前列腺病灶检测的数据融合策略比较。
Radiat Oncol. 2024 Jul 29;19(1):96. doi: 10.1186/s13014-024-02471-0.
3
Clinical value of minimum apparent diffusion coefficient for prediction of clinically significant prostate cancer in the transition zone.最小表观扩散系数对预测移行区临床显著前列腺癌的临床价值。
Int J Clin Oncol. 2023 May;28(5):716-723. doi: 10.1007/s10147-023-02324-y. Epub 2023 Mar 24.
4
Comparison of Diffusion Kurtosis Imaging and Standard Mono-Exponential Apparent Diffusion Coefficient in Diagnosis of Significant Prostate Cancer-A Correlation with Gleason Score Assessed on Whole-Mount Histopathology Specimens.扩散峰度成像与标准单指数表观扩散系数在显著前列腺癌诊断中的比较——与基于全层组织病理学标本评估的 Gleason 评分的相关性
Diagnostics (Basel). 2023 Jan 4;13(2):173. doi: 10.3390/diagnostics13020173.
5
Fully automated detection and localization of clinically significant prostate cancer on MR images using a cascaded convolutional neural network.使用级联卷积神经网络在磁共振图像上全自动检测和定位具有临床意义的前列腺癌。
Front Oncol. 2022 Sep 29;12:958065. doi: 10.3389/fonc.2022.958065. eCollection 2022.
6
Segmentation of the prostate, its zones, anterior fibromuscular stroma, and urethra on the MRIs and multimodality image fusion using U-Net model.使用U-Net模型对前列腺及其区域、前部纤维肌基质和尿道进行MRI分割以及多模态图像融合。
Quant Imaging Med Surg. 2022 Oct;12(10):4786-4804. doi: 10.21037/qims-22-115.
7
MRI apparent diffusion coefficient (ADC): A biomarker for prostate cancer after radiation therapy.磁共振成像表观扩散系数(ADC):放射治疗后前列腺癌的生物标志物。
Turk J Urol. 2021 Nov;47(6):448-451. doi: 10.5152/tud.2021.21274.
8
Synthetic Apparent Diffusion Coefficient for High -Value Diffusion-Weighted MRI in Prostate.前列腺高值扩散加权磁共振成像的合成表观扩散系数
Prostate Cancer. 2020 Feb 10;2020:5091218. doi: 10.1155/2020/5091218. eCollection 2020.
9
Early Second Round Targeted Biopsy of PI-RADS Score 3 or 4 in 256 Men With Persistent Suspicion of Prostate Cancer.对256名仍怀疑患有前列腺癌的男性进行PI-RADS 3或4分的早期第二轮靶向活检。
In Vivo. 2019 May-Jun;33(3):897-901. doi: 10.21873/invivo.11556.
10
Multiparametric MRI Apparent Diffusion Coefficient (ADC) Accuracy in Diagnosing Clinically Significant Prostate Cancer.多参数磁共振成像表观扩散系数(ADC)在诊断具有临床意义的前列腺癌中的准确性
In Vivo. 2017 May-Jun;31(3):415-418. doi: 10.21873/invivo.11075.

本文引用的文献

1
Are biomarkers evaluated in biopsy specimens predictive of prostate cancer aggressiveness?在活检标本中评估的生物标志物能否预测前列腺癌的侵袭性?
J Cancer Res Clin Oncol. 2016 Jan;142(1):201-12. doi: 10.1007/s00432-015-2015-1. Epub 2015 Jul 26.
2
Twelve Core Template Prostate Biopsy is an Unreliable Tool to Select Patients Eligible for Focal Therapy.
Urol Int. 2015;95(2):197-202. doi: 10.1159/000381559. Epub 2015 Apr 18.
3
Comprehensive assessment for novel prostate cancer markers in the prostate-specific antigen era: focusing on Asians and Asian countries.前列腺特异性抗原时代新型前列腺癌标志物的综合评估:聚焦亚洲人和亚洲国家。
Int J Urol. 2015 Apr;22(4):334-41. doi: 10.1111/iju.12701.
4
Diffusion-weighted magnetic resonance imaging for prediction of insignificant prostate cancer in potential candidates for active surveillance.扩散加权磁共振成像用于预测主动监测潜在候选者中低危前列腺癌
Eur Radiol. 2015 Jun;25(6):1786-92. doi: 10.1007/s00330-014-3566-2. Epub 2015 Jan 31.
5
Multiparametric magnetic resonance imaging/transrectal ultrasound fusion targeted biopsy of the prostate: preliminary results of a prospective single-centre study.多参数磁共振成像/经直肠超声融合靶向前列腺活检:一项前瞻性单中心研究的初步结果
Urol Int. 2015;94(3):313-8. doi: 10.1159/000365489. Epub 2015 Jan 9.
6
Complications of transrectal ultrasound-guided prostate biopsy: impact of prebiopsy enema.经直肠超声引导下前列腺穿刺活检的并发症:活检前灌肠的影响
Korean J Urol. 2014 Nov;55(11):732-6. doi: 10.4111/kju.2014.55.11.732. Epub 2014 Nov 10.
7
Novel tools to improve patient selection and monitoring on active surveillance for low-risk prostate cancer: a systematic review.改善主动监测低危前列腺癌患者选择和监测的新工具:系统评价。
Eur Urol. 2014 Jun;65(6):1023-31. doi: 10.1016/j.eururo.2014.01.027. Epub 2014 Jan 28.
8
Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient.前列腺癌侵袭性:表观扩散系数全病变直方图分析评估。
Radiology. 2014 Apr;271(1):143-52. doi: 10.1148/radiol.13130973. Epub 2013 Dec 12.
9
Comparison between Gleason score and apparent diffusion coefficient obtained from diffusion-weighted imaging of prostate cancer patients.前列腺癌患者弥散加权成像表观弥散系数与 Gleason 评分的比较。
Cancer Invest. 2013 Nov;31(9):625-9. doi: 10.3109/07357907.2013.845673. Epub 2013 Oct 18.
10
The role of magnetic resonance imaging in the diagnosis and management of prostate cancer.磁共振成像在前列腺癌诊断和治疗中的作用。
BJU Int. 2013 Nov;112 Suppl 2:6-20. doi: 10.1111/bju.12381.

前列腺癌患者中Gleason评分与扩散加权磁共振成像表观扩散系数之间的关系。

Relationship between Gleason score and apparent diffusion coefficients of diffusion-weighted magnetic resonance imaging in prostate cancer patients.

作者信息

Kim Tae Heon, Kim Chan Kyo, Park Byung Kwan, Jeon Hwang Gyun, Jeong Byung Chang, Seo Seong Il, Lee Hyun Moo, Choi Han Yong, Jeon Seong Soo

机构信息

Department of Urology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea.

Department of Radiology, Samsung Medical Centre, Sungkyunkwan University School of Medicine, Seoul, Korea.

出版信息

Can Urol Assoc J. 2016 Nov-Dec;10(11-12):E377-E382. doi: 10.5489/cuaj.3896. Epub 2016 Nov 10.

DOI:10.5489/cuaj.3896
PMID:28096922
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5234404/
Abstract

INTRODUCTION

We assessed the correlation between the apparent diffusion coefficient (ADC) and pathological Gleason score (GS) of prostate cancer patients.

METHODS

A total of 125 patients who underwent multiparametric magnetic resonance imaging before radical prostatectomy for prostate cancer were included in this study. ADC values were compared with different GS. We used receiver operating characteristic analysis and determined the ADC cutoff value to differentiate tumours with a GS of 6 from those with a GS ≥7.

RESULTS

We identified 34 patients (27.2%) with a GS of 6; 33 patients (26.4%) with a GS of 7; 22 patients (17.6%) with a GS of 8; and 36 patients (28.8%) with a GS of ≥9. The mean ADC value for disease with a GS of 6 was 0.914 ± 0.161 ×10 mm/s; GS of 7: 0.741 ± 0.164 ×10 mm/s; GS of 8: 0.679 ± 0.130 ×10 mm/s; and GS of ≥9: 0.593 ± 0.089 ×10 mm/s. An ADC value of 0.830 ×10mm/s was the best cutoff value to identify prostate cancer with a GS of 6.

CONCLUSIONS

We observed an inverse relationship between GS and ADC value. Moreover, a cutoff ADC value may help differentiate disease with a GS of 6 from disease with a GS ≥7.

摘要

引言

我们评估了前列腺癌患者的表观扩散系数(ADC)与病理Gleason评分(GS)之间的相关性。

方法

本研究纳入了125例在前列腺癌根治性前列腺切除术前行多参数磁共振成像的患者。将ADC值与不同的GS进行比较。我们采用受试者工作特征分析,并确定了ADC临界值,以区分GS为6的肿瘤与GS≥7的肿瘤。

结果

我们确定了34例(27.2%)GS为6的患者;33例(26.4%)GS为7的患者;22例(17.6%)GS为8的患者;以及36例(28.8%)GS≥9的患者。GS为6的疾病的平均ADC值为0.914±0.161×10⁻³mm²/s;GS为7的疾病:0.741±0.164×10⁻³mm²/s;GS为8的疾病:0.679±0.130×10⁻³mm²/s;GS≥9的疾病:0.593±0.089×10⁻³mm²/s。ADC值为0.830×10⁻³mm²/s是识别GS为6的前列腺癌的最佳临界值。

结论

我们观察到GS与ADC值之间呈负相关。此外,ADC临界值可能有助于区分GS为6的疾病与GS≥7的疾病。